Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Dermoscopic follow-up of therapeutic response in mantle cell lymphoma with secondary involvement of the scalp.

Swoboda R, Kaminska-Winciorek G, Jaworska M, Giebel S.

J Cosmet Dermatol. 2018 Dec 5. doi: 10.1111/jocd.12826. [Epub ahead of print]

PMID:
30520227
2.

An integrated expression atlas of miRNAs and their promoters in human and mouse.

de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, Åström G, Babina M, Bertin N, Burroughs AM, Carlisle AJ, Daub CO, Detmar M, Deviatiiarov R, Fort A, Gebhard C, Goldowitz D, Guhl S, Ha TJ, Harshbarger J, Hasegawa A, Hashimoto K, Herlyn M, Heutink P, Hitchens KJ, Hon CC, Huang E, Ishizu Y, Kai C, Kasukawa T, Klinken P, Lassmann T, Lecellier CH, Lee W, Lizio M, Makeev V, Mathelier A, Medvedeva YA, Mejhert N, Mungall CJ, Noma S, Ohshima M, Okada-Hatakeyama M, Persson H, Rizzu P, Roudnicky F, Sætrom P, Sato H, Severin J, Shin JW, Swoboda RK, Tarui H, Toyoda H, Vitting-Seerup K, Winteringham L, Yamaguchi Y, Yasuzawa K, Yoneda M, Yumoto N, Zabierowski S, Zhang PG, Wells CA, Summers KM, Kawaji H, Sandelin A, Rehli M; FANTOM Consortium, Hayashizaki Y, Carninci P, Forrest ARR, de Hoon MJL.

Nat Biotechnol. 2017 Sep;35(9):872-878. doi: 10.1038/nbt.3947. Epub 2017 Aug 21.

3.

The age of developing diabetes and FTO polymorphisms (rs9939609, rs1421085, and rs9930506).

Grzeszczak W, Molsa M, Tłuczykont M, Markowicz A, Swoboda R, Biedak M, Kałuża A, Sirek S, Strojek K.

Endokrynol Pol. 2017;68(4):402-406. doi: 10.5603/EP.a2017.0032. Epub 2017 Jun 6.

4.

Platelet count and volume indices in patients with contrast-induced acute kidney injury and acute myocardial infarction treated invasively.

Francuz P, Kowalczyk J, Swoboda R, Przybylska-Siedlecka K, Kozieł M, Podolecki T, Świątkowski A, Lenarczyk R, Średniawa B, Kalarus Z.

Kardiol Pol. 2015;73(7):520-6. doi: 10.5603/KP.a2015.0054. Epub 2015 Mar 12.

5.

Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.

Arner E, Daub CO, Vitting-Seerup K, Andersson R, Lilje B, Drabløs F, Lennartsson A, Rönnerblad M, Hrydziuszko O, Vitezic M, Freeman TC, Alhendi AM, Arner P, Axton R, Baillie JK, Beckhouse A, Bodega B, Briggs J, Brombacher F, Davis M, Detmar M, Ehrlund A, Endoh M, Eslami A, Fagiolini M, Fairbairn L, Faulkner GJ, Ferrai C, Fisher ME, Forrester L, Goldowitz D, Guler R, Ha T, Hara M, Herlyn M, Ikawa T, Kai C, Kawamoto H, Khachigian LM, Klinken SP, Kojima S, Koseki H, Klein S, Mejhert N, Miyaguchi K, Mizuno Y, Morimoto M, Morris KJ, Mummery C, Nakachi Y, Ogishima S, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov D, Passier R, Patrikakis M, Pombo A, Qin XY, Roy S, Sato H, Savvi S, Saxena A, Schwegmann A, Sugiyama D, Swoboda R, Tanaka H, Tomoiu A, Winteringham LN, Wolvetang E, Yanagi-Mizuochi C, Yoneda M, Zabierowski S, Zhang P, Abugessaisa I, Bertin N, Diehl AD, Fukuda S, Furuno M, Harshbarger J, Hasegawa A, Hori F, Ishikawa-Kato S, Ishizu Y, Itoh M, Kawashima T, Kojima M, Kondo N, Lizio M, Meehan TF, Mungall CJ, Murata M, Nishiyori-Sueki H, Sahin S, Nagao-Sato S, Severin J, de Hoon MJ, Kawai J, Kasukawa T, Lassmann T, Suzuki H, Kawaji H, Summers KM, Wells C; FANTOM Consortium, Hume DA, Forrest AR, Sandelin A, Carninci P, Hayashizaki Y.

Science. 2015 Feb 27;347(6225):1010-4. doi: 10.1126/science.1259418. Epub 2015 Feb 12.

6.

Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.

Swoboda RK, Somasundaram R, Caputo-Gross L, Marincola FM, Robbins P, Herlyn M, Herlyn D.

Mol Ther Oncolytics. 2015 Jan 14;1:14009. doi: 10.1038/mto.2014.9. eCollection 2015.

7.

A promoter-level mammalian expression atlas.

FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M, Andersson R, Mungall CJ, Meehan TF, Schmeier S, Bertin N, Jørgensen M, Dimont E, Arner E, Schmidl C, Schaefer U, Medvedeva YA, Plessy C, Vitezic M, Severin J, Semple C, Ishizu Y, Young RS, Francescatto M, Alam I, Albanese D, Altschuler GM, Arakawa T, Archer JA, Arner P, Babina M, Rennie S, Balwierz PJ, Beckhouse AG, Pradhan-Bhatt S, Blake JA, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Burroughs AM, Califano A, Cannistraci CV, Carbajo D, Chen Y, Chierici M, Ciani Y, Clevers HC, Dalla E, Davis CA, Detmar M, Diehl AD, Dohi T, Drabløs F, Edge AS, Edinger M, Ekwall K, Endoh M, Enomoto H, Fagiolini M, Fairbairn L, Fang H, Farach-Carson MC, Faulkner GJ, Favorov AV, Fisher ME, Frith MC, Fujita R, Fukuda S, Furlanello C, Furino M, Furusawa J, Geijtenbeek TB, Gibson AP, Gingeras T, Goldowitz D, Gough J, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Harbers M, Harshbarger J, Hasegawa A, Hasegawa Y, Hashimoto T, Herlyn M, Hitchens KJ, Ho Sui SJ, Hofmann OM, Hoof I, Hori F, Huminiecki L, Iida K, Ikawa T, Jankovic BR, Jia H, Joshi A, Jurman G, Kaczkowski B, Kai C, Kaida K, Kaiho A, Kajiyama K, Kanamori-Katayama M, Kasianov AS, Kasukawa T, Katayama S, Kato S, Kawaguchi S, Kawamoto H, Kawamura YI, Kawashima T, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klinken SP, Knox AJ, Kojima M, Kojima S, Kondo N, Koseki H, Koyasu S, Krampitz S, Kubosaki A, Kwon AT, Laros JF, Lee W, Lennartsson A, Li K, Lilje B, Lipovich L, Mackay-Sim A, Manabe R, Mar JC, Marchand B, Mathelier A, Mejhert N, Meynert A, Mizuno Y, de Lima Morais DA, Morikawa H, Morimoto M, Moro K, Motakis E, Motohashi H, Mummery CL, Murata M, Nagao-Sato S, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nakazato K, van Nimwegen E, Ninomiya N, Nishiyori H, Noma S, Noma S, Noazaki T, Ogishima S, Ohkura N, Ohimiya H, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Pain A, Passier R, Patrikakis M, Persson H, Piazza S, Prendergast JG, Rackham OJ, Ramilowski JA, Rashid M, Ravasi T, Rizzu P, Roncador M, Roy S, Rye MB, Saijyo E, Sajantila A, Saka A, Sakaguchi S, Sakai M, Sato H, Savvi S, Saxena A, Schneider C, Schultes EA, Schulze-Tanzil GG, Schwegmann A, Sengstag T, Sheng G, Shimoji H, Shimoni Y, Shin JW, Simon C, Sugiyama D, Sugiyama T, Suzuki M, Suzuki N, Swoboda RK, 't Hoen PA, Tagami M, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tatum Z, Thompson M, Toyodo H, Toyoda T, Valen E, van de Wetering M, van den Berg LM, Verado R, Vijayan D, Vorontsov IE, Wasserman WW, Watanabe S, Wells CA, Winteringham LN, Wolvetang E, Wood EJ, Yamaguchi Y, Yamamoto M, Yoneda M, Yonekura Y, Yoshida S, Zabierowski SE, Zhang PG, Zhao X, Zucchelli S, Summers KM, Suzuki H, Daub CO, Kawai J, Heutink P, Hide W, Freeman TC, Lenhard B, Bajic VB, Taylor MS, Makeev VJ, Sandelin A, Hume DA, Carninci P, Hayashizaki Y.

Nature. 2014 Mar 27;507(7493):462-70. doi: 10.1038/nature13182.

8.

Break-up of droplets in a concentrated emulsion flowing through a narrow constriction.

Rosenfeld L, Fan L, Chen Y, Swoboda R, Tang SK.

Soft Matter. 2014 Jan 21;10(3):421-30. doi: 10.1039/c3sm51843d.

PMID:
24651830
9.

Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.

Villanueva J, Infante JR, Krepler C, Reyes-Uribe P, Samanta M, Chen HY, Li B, Swoboda RK, Wilson M, Vultur A, Fukunaba-Kalabis M, Wubbenhorst B, Chen TY, Liu Q, Sproesser K, DeMarini DJ, Gilmer TM, Martin AM, Marmorstein R, Schultz DC, Speicher DW, Karakousis GC, Xu W, Amaravadi RK, Xu X, Schuchter LM, Herlyn M, Nathanson KL.

Cell Rep. 2013 Sep 26;4(6):1090-9. doi: 10.1016/j.celrep.2013.08.023. Epub 2013 Sep 19.

10.

There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Swoboda RK, Herlyn M.

Exp Dermatol. 2013 May;22(5):303-6. doi: 10.1111/exd.12117. Epub 2013 Mar 12.

11.

Recipients affect prosocial and altruistic choices in jackdaws, Corvus monedula.

Schwab C, Swoboda R, Kotrschal K, Bugnyar T.

PLoS One. 2012;7(4):e34922. doi: 10.1371/journal.pone.0034922. Epub 2012 Apr 12.

12.

Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Francuz P, Swoboda R, Lenarczyk R, Sredniawa B, Golda A, Kurek T, Mazurek M, Podolecki T, Polonski L, Kalarus Z.

Nephron Clin Pract. 2010;116(2):c114-22. doi: 10.1159/000314660. Epub 2010 May 21.

PMID:
20502047
13.

Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.

Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D.

Int J Cancer. 2010 Sep 1;127(5):1124-30. doi: 10.1002/ijc.25133.

14.

SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists.

Hurth K, Enz A, Floersheim P, Gentsch C, Hoyer D, Langenegger D, Neumann P, Pfäffli P, Sorg D, Swoboda R, Vassout A, Troxler T.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3988-91. Epub 2007 Apr 30.

PMID:
17512199
15.

Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists.

Troxler T, Hoyer D, Langenegger D, Neumann P, Pfäffli P, Schoeffter P, Sorg D, Swoboda R, Hurth K.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3983-7. Epub 2007 Apr 29.

PMID:
17507221
16.

Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.

Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D.

Cancer Res. 2007 Apr 15;67(8):3555-9.

17.

High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.

Wei Q, Clarke L, Scheidenhelm DK, Qian B, Tong A, Sabha N, Karim Z, Bock NA, Reti R, Swoboda R, Purev E, Lavoie JF, Bajenaru ML, Shannon P, Herlyn D, Kaplan D, Henkelman RM, Gutmann DH, Guha A.

Cancer Res. 2006 Aug 1;66(15):7429-37.

18.

Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.

Berencsi K, Meropol NJ, Hoffman JP, Sigurdson E, Giles L, Rani P, Somasundaram R, Zhang T, Kalabis J, Caputo L, Furth E, Swoboda R, Marincola F, Herlyn D.

Cancer Immunol Immunother. 2007 Mar;56(3):359-70. Epub 2006 Jun 17.

PMID:
16783574
19.

Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.

Somasundaram R, Swoboda R, Caputo L, Otvos L, Weber B, Volpe P, van Belle P, Hotz S, Elder DE, Marincola FM, Schuchter L, Guerry D, Czerniecki BJ, Herlyn D.

Cancer Res. 2006 Mar 15;66(6):3287-93.

20.

Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.

Zhang T, Somasundaram R, Berencsi K, Caputo L, Gimotty P, Rani P, Guerry D, Swoboda R, Herlyn D.

Eur J Immunol. 2006 Feb;36(2):457-67.

21.

Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.

Furth EE, Li J, Purev E, Solomon AC, Rogler G, Mick R, Putt M, Zhang T, Somasundaram R, Swoboda R, Herlyn D.

Cancer Immunol Immunother. 2006 May;55(5):528-37. Epub 2005 Jul 21.

PMID:
16034560
22.

CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.

Zhang T, Somasundaram R, Berencsi K, Caputo L, Rani P, Guerry D, Furth E, Rollins BJ, Putt M, Gimotty P, Swoboda R, Herlyn M, Herlyn D.

J Immunol. 2005 May 1;174(9):5856-63.

23.

Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).

Purev E, Cai D, Miller E, Swoboda R, Mayer T, Klein-Szanto A, Marincola FM, Mick R, Otvos L, Wunner W, Birebent B, Somasundaram R, Wikstrand CJ, Bigner D, DeMichele A, Acs G, Berlin JA, Herlyn D.

J Immunol. 2004 Nov 15;173(10):6472-80.

24.

Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic mice.

Li J, Li W, Liang S, Cai D, Kieny MP, Jacob L, Linnenbach A, Abramczuk JW, Bender H, Sproesser K, Swoboda R, Somasundaram R, Guerry D, Herlyn D.

J Immunol. 2003 Sep 15;171(6):2922-9.

25.

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.

Basak S, Birebent B, Purev E, Somasundaram R, Maruyama H, Zaloudik J, Swoboda R, Strittmatter W, Li W, Luckenbach A, Song H, Li J, Sproesser K, Guerry D, Nair S, Furukawa K, Herlyn D.

Cancer Immunol Immunother. 2003 Mar;52(3):145-54. Epub 2003 Feb 11.

PMID:
12649743
26.

A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.

Somasundaram R, Swoboda R, Caputo L, Lee A, Jackson N, Marincola FM, Guerry D, Herlyn D.

Int J Cancer. 2003 Apr 10;104(3):362-8.

27.

Sec20p-interacting proteins (Tip20p, Ufe1p) in the retrograde secretory pathway of the fungal pathogen Candida albicans.

Weber Y, Swoboda RK, Ernst JF.

Mol Genet Genomics. 2002 Dec;268(4):468-76. Epub 2002 Nov 16.

PMID:
12471444
28.

Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta.

Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S, Monos D, Peritt D, Marincola F, Cai D, Birebent B, Bloome E, Kim J, Berencsi K, Mastrangelo M, Herlyn D.

Cancer Res. 2002 Sep 15;62(18):5267-72.

29.

A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.

Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL Jr.

J Infect Dis. 2002 May 1;185(9):1269-76. Epub 2002 Apr 16.

PMID:
12001044
30.

Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis.

Slavinsky J 3rd, Myers T, Swoboda RK, Leigh JE, Hager S, Fidel PL Jr.

Oral Microbiol Immunol. 2002 Feb;17(1):38-43.

PMID:
11860554
31.

Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.

Steele C, Leigh J, Swoboda R, Ozenci H, Fidel PL Jr.

Infect Immun. 2001 Nov;69(11):7091-9.

32.

Isolation of the melanoma-associated antigen p23 using antibody phage display.

Li J, Pereira S, Van Belle P, Tsui P, Elder D, Speicher D, Deen K, Linnenbach A, Somasundaram R, Swoboda R, Herlyn D.

J Immunol. 2001 Jan 1;166(1):432-8.

33.

Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.

Leigh JE, Barousse M, Swoboda RK, Myers T, Hager S, Wolf NA, Cutright JL, Thompson J, Sobel JD, Fidel PL Jr.

J Infect Dis. 2001 Jan 15;183(2):277-285. Epub 2000 Dec 13.

PMID:
11120933
35.

Growth inhibition of Candida by human oral epithelial cells.

Steele C, Leigh J, Swoboda R, Fidel PL Jr.

J Infect Dis. 2000 Nov;182(5):1479-85. Epub 2000 Oct 9.

PMID:
11023471
36.

In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.

Taylor BN, Fichtenbaum C, Saavedra M, Slavinsky III J, Swoboda R, Wozniak K, Arribas A, Powderly W, Fidel PL Jr.

J Infect Dis. 2000 Sep;182(3):955-9. Epub 2000 Aug 17.

PMID:
10950797
37.

Cytoskeletal proteins and morphogenesis in Candida albicans and Yarrowia lipolytica.

Kurischko C, Swoboda RK.

Contrib Microbiol. 2000;5:173-84. Review. No abstract available.

PMID:
10863672
38.

Sequence analysis of SLA2 of the dimorphic yeasts Candida albicans and Yarrowia lipolytica.

Melms AS, Gausmann U, Swoboda RK, Dominguez A, Kurischko C.

Yeast. 1999 Oct;15(14):1519-28.

39.

Combined Fmoc-Alloc strategy for a general SPPS of phosphoserine peptides; preparation of phosphorylation-dependent tau antisera.

Shapiro G, Büchler D, Dalvit C, Frey P, Fernández MC, Gomez-Lor B, Pombo-Villar E, Stauss U, Swoboda R, Waridel C.

Bioorg Med Chem. 1997 Jan;5(1):147-56.

PMID:
9043666
40.

The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities.

Klafki H, Abramowski D, Swoboda R, Paganetti PA, Staufenbiel M.

J Biol Chem. 1996 Nov 8;271(45):28655-9.

41.

Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase.

Bertram G, Swoboda RK, Gooday GW, Gow NA, Brown AJ.

Yeast. 1996 Feb;12(2):115-27.

42.

Structure and regulation of the Hsp90 gene from the pathogenic fungus Candida albicans.

Swoboda RK, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

Infect Immun. 1996 Feb;64(2):680. No abstract available.

43.

Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells.

Buchet R, Tavitian E, Ristig D, Swoboda R, Stauss U, Gremlich HU, de La Fournière L, Staufenbiel M, Frey P, Lowe DA.

Biochim Biophys Acta. 1996 Jan 17;1315(1):40-6.

44.

Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans.

Swoboda RK, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

Infect Immun. 1995 Nov;63(11):4506-14. Erratum in: Infect Immun. 1996 Feb;64(2):680.

45.

Structure and regulation of a Candida albicans RP10 gene which encodes an immunogenic protein homologous to Saccharomyces cerevisiae ribosomal protein 10.

Swoboda RK, Broadbent ID, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

J Bacteriol. 1995 Mar;177(5):1239-46.

46.

Regulation of the gene encoding translation elongation factor 3 during growth and morphogenesis in Candida albicans.

Swoboda RK, Bertram G, Colthurst DR, Tuite MF, Gow NA, Gooday GW, Brown AJ.

Microbiology. 1994 Oct;140 ( Pt 10):2611-6.

PMID:
8000530
48.

Fluctuations in glycolytic mRNA levels during morphogenesis in Candida albicans reflect underlying changes in growth and are not a response to cellular dimorphism.

Swoboda RK, Bertram G, Delbrück S, Ernst JF, Gow NA, Gooday GW, Brown AJ.

Mol Microbiol. 1994 Aug;13(4):663-72.

PMID:
7997178
49.

Heat-inducible ATP-binding proteins of Candida albicans are recognized by sera of infected patients.

Swoboda R, Miyasaki S, Greenspan D, Greenspan JS.

J Gen Microbiol. 1993 Dec;139(12):2995-3003.

PMID:
8126425
50.

Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Swoboda RK, Bertram G, Hollander H, Greenspan D, Greenspan JS, Gow NA, Gooday GW, Brown AJ.

Infect Immun. 1993 Oct;61(10):4263-71.

Supplemental Content

Loading ...
Support Center